Radiation Therapy Market (Type: External Beam Radiation Therapy and Internal Radiation Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Description
Radiation Therapy Market (Type: External Beam Radiation Therapy and Internal Radiation Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
Companies Mentioned
Elekta AB
Varian Medical Systems
IBA Radiopharma Solutions
Accuray Incorporated
Isoray, Inc.
Mevion Medical Systems
Hitachi, Ltd.
ViewRay, Inc.
Panacea Medical Technologies Pvt. Ltd.
Countries
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Forecast Year (first) - 2022
Forecast Year (last) - 2031
Forecast Year ( first) Value - 6.3
Forecast Year (last) Value - 10.6
CAGR % - 5.4%
Currency - US$ Bn
Companies Mentioned
Elekta AB
Varian Medical Systems
IBA Radiopharma Solutions
Accuray Incorporated
Isoray, Inc.
Mevion Medical Systems
Hitachi, Ltd.
ViewRay, Inc.
Panacea Medical Technologies Pvt. Ltd.
Countries
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Forecast Year (first) - 2022
Forecast Year (last) - 2031
Forecast Year ( first) Value - 6.3
Forecast Year (last) Value - 10.6
CAGR % - 5.4%
Currency - US$ Bn
Table of Contents
183 Pages
- 1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Radiation Therapy Market
- 4. Market Overview
- 4.1. Introduction
- 4.1.1. Therapy Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Radiation Therapy Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
- 5. Market Outlook
- 5.1. Healthcare Industry Overview
- 6. Global Radiation Therapy Market Analysis and Forecast, by Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Type, 2017-2031
- 6.3.1. External Beam Radiation Therapy
- 6.3.1.1. Conformal Radiation Therapy
- 6.3.1.2. Proton Beam Therapy
- 6.3.1.3. Image-guided Radiation Therapy
- 6.3.1.4. Stereotactic Radiation Therapy
- 6.3.1.5. Others
- 6.3.2. Internal Radiation Therapy
- 6.3.2.1. Brachytherapy
- 6.3.2.2. Systemic Radiation Therapy
- 6.4. Market Attractiveness Analysis, by Type
- 7. Global Radiation Therapy Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by End-user, 2017-2031
- 7.3.1. Hospitals
- 7.3.2. Specialty Clinics
- 7.3.3. Others
- 7.4. Market Attractiveness Analysis, by End-user
- 8. Global Radiation Therapy Market Analysis and Forecast, by Region
- 8.1. Key Findings
- 8.2. Market Value Forecast, by Region
- 8.2.1. North America
- 8.2.2. Europe
- 8.2.3. Asia Pacific
- 8.2.4. Latin America
- 8.2.5. Middle East & Africa
- 8.3. Market Attractiveness Analysis, by Region
- 9. North America Radiation Therapy Market Analysis and Forecast
- 9.1. Introduction
- 9.1.1. Key Findings
- 9.2. Market Value Forecast, by Type, 2017-2031
- 9.2.1. External Beam Radiation Therapy
- 9.2.1.1. Conformal Radiation Therapy
- 9.2.1.2. Proton Beam Therapy
- 9.2.1.3. Image-guided Radiation Therapy
- 9.2.1.4. Stereotactic Radiation Therapy
- 9.2.1.5. Others
- 9.2.2. Internal Radiation Therapy
- 9.2.2.1. Brachytherapy
- 9.2.2.2. Systemic Radiation Therapy
- 9.3. Market Value Forecast, by End-user, 2017-2031
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Others
- 9.4. Market Value Forecast, by Country, 2017-2031
- 9.4.1. U.S.
- 9.4.2. Canada
- 9.5. Market Attractiveness Analysis
- 9.5.1. By Type
- 9.5.2. By End-user
- 9.5.3. By Country
- 10. Europe Radiation Therapy Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Type, 2017-2031
- 10.2.1. External Beam Radiation Therapy
- 10.2.1.1. Conformal Radiation Therapy
- 10.2.1.2. Proton Beam Therapy
- 10.2.1.3. Image-guided Radiation Therapy
- 10.2.1.4. Stereotactic Radiation Therapy
- 10.2.1.5. Others
- 10.2.2. Internal Radiation Therapy
- 10.2.2.1. Brachytherapy
- 10.2.2.2. Systemic Radiation Therapy
- 10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Specialty Clinics
- 10.3.3. Others
- 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 10.4.1. Germany
- 10.4.2. U.K.
- 10.4.3. France
- 10.4.4. Spain
- 10.4.5. Italy
- 10.4.6. Rest of Europe
- 10.5. Market Attractiveness Analysis
- 10.5.1. By Type
- 10.5.2. By End-user
- 10.5.3. By Country/Sub-region
- 11. Asia Pacific Radiation Therapy Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Type, 2017-2031
- 11.2.1. External Beam Radiation Therapy
- 11.2.1.1. Conformal Radiation Therapy
- 11.2.1.2. Proton Beam Therapy
- 11.2.1.3. Image-guided Radiation Therapy
- 11.2.1.4. Stereotactic Radiation Therapy
- 11.2.1.5. Others
- 11.2.2. Internal Radiation Therapy
- 11.2.2.1. Brachytherapy
- 11.2.2.2. Systemic Radiation Therapy
- 11.3. Market Value Forecast, by End-user, 2017-2031
- 11.3.1. Hospitals
- 11.3.2. Specialty Clinics
- 11.3.3. Others
- 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.4.1. China
- 11.4.2. Japan
- 11.4.3. India
- 11.4.4. Australia & New Zealand
- 11.4.5. Rest of Asia Pacific
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Type
- 11.5.2. By End-user
- 11.5.3. By Country/Sub-region
- 12. Latin America Radiation Therapy Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Type, 2017-2031
- 12.2.1. External Beam Radiation Therapy
- 12.2.1.1. Conformal Radiation Therapy
- 12.2.1.2. Proton Beam Therapy
- 12.2.1.3. Image-guided Radiation Therapy
- 12.2.1.4. Stereotactic Radiation Therapy
- 12.2.1.5. Others
- 12.2.2. Internal Radiation Therapy
- 12.2.2.1. Brachytherapy
- 12.2.2.2. Systemic Radiation Therapy
- 12.3. Market Value Forecast, by End-user, 2017-2031
- 12.3.1. Hospitals
- 12.3.2. Specialty Clinics
- 12.3.3. Others
- 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.4.1. Brazil
- 12.4.2. Mexico
- 12.4.3. Rest of Latin America
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Type
- 12.5.2. By End-user
- 12.5.3. By Country/Sub-region
- 13. Middle East & Africa Radiation Therapy Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Type, 2017-2031
- 13.2.1. External Beam Radiation Therapy
- 13.2.1.1. Conformal Radiation Therapy
- 13.2.1.2. Proton Beam Therapy
- 13.2.1.3. Image-guided Radiation Therapy
- 13.2.1.4. Stereotactic Radiation Therapy
- 13.2.1.5. Others
- 13.2.2. Internal Radiation Therapy
- 13.2.2.1. Brachytherapy
- 13.2.2.2. Systemic Radiation Therapy
- 13.3. Market Value Forecast, by End-user, 2017-2031
- 13.3.1. Hospitals
- 13.3.2. Specialty Clinics
- 13.3.3. Others
- 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.4.1. GCC Countries
- 13.4.2. South Africa
- 13.4.3. Rest of Middle East & Africa
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Type
- 13.5.2. By End-user
- 13.5.3. By Country/Sub-region
- 14. Competition Landscape
- 14.1. Market Player - Competition Matrix (by tier and size of companies)
- 14.2. Market Share Analysis, by Company, 2021
- 14.3. Company Profiles
- 14.3.1. Elekta AB
- 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.1.2. Financial Overview
- 14.3.1.3. Product Portfolio
- 14.3.1.4. SWOT Analysis
- 14.3.1.5. Strategic Overview
- 14.3.2. Varian Medical Systems
- 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.2.2. Financial Overview
- 14.3.2.3. Product Portfolio
- 14.3.2.4. SWOT Analysis
- 14.3.2.5. Strategic Overview
- 14.3.3. IBA Radiopharma Solutions
- 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.3.2. Financial Overview
- 14.3.3.3. Product Portfolio
- 14.3.3.4. SWOT Analysis
- 14.3.3.5. Strategic Overview
- 14.3.4. Accuray Incorporated
- 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.4.2. Financial Overview
- 14.3.4.3. Product Portfolio
- 14.3.4.4. SWOT Analysis
- 14.3.4.5. Strategic Overview
- 14.3.5. Isoray, Inc.
- 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.5.2. Financial Overview
- 14.3.5.3. Product Portfolio
- 14.3.5.4. SWOT Analysis
- 14.3.5.5. Strategic Overview
- 14.3.6. Mevion Medical Systems
- 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.6.2. Financial Overview
- 14.3.6.3. Product Portfolio
- 14.3.6.4. SWOT Analysis
- 14.3.6.5. Strategic Overview
- 14.3.7. Hitachi, Ltd.
- 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.7.2. Financial Overview
- 14.3.7.3. Product Portfolio
- 14.3.7.4. SWOT Analysis
- 14.3.7.5. Strategic Overview
- 14.3.8. ViewRay, Inc.
- 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.8.2. Financial Overview
- 14.3.8.3. Product Portfolio
- 14.3.8.4. SWOT Analysis
- 14.3.8.5. Strategic Overview
- 14.3.9. Panacea Medical Technologies Pvt. Ltd.
- 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 14.3.9.2. Financial Overview
- 14.3.9.3. Product Portfolio
- 14.3.9.4. SWOT Analysis
- 14.3.9.5. Strategic Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



